Informations sur le produit
Nom :
Trelagliptin
Synonymes :
- (R)-2-[[6-(3-Aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl]methyl]-4-fluorobenzonitrile
- 2-[[6-[(3R)-3-Amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-4-fluorobenzonitrile
- (R)-2-[[6-(3-AMinopiperidin-1-yl)-3-Methyl-2,4-dioxo-3,4-dihydropyriMidin-1(2H)-yl]Methyl]-4-fluorobenzonitrile
- Benzonitrile, 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-4-fluoro-
Description :
Trelagliptin is a potent, selective and orally active agonist of the glucagon-like peptide-1 receptor (GLP-1R) that improves glucose homeostasis in patients with type 2 diabetes. Trelagliptin has been shown to increase insulin secretion and reduce postprandial hyperglycemia. The drug binds to GLP-1Rs on the surface of beta cells in the pancreas. This binding stimulates cAMP production, leading to increased insulin release from pancreatic beta cells. Trelagliptin is chemically stable in human serum, exhibiting no significant changes after incubation for up to 72 hours at 37°C.
Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :
Propriétés chimiques
Masse moléculaire :
357.38 g/mol
Formule :
C18H20FN5O2
Degré de pureté :
Min. 95%
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :
